These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1959497)

  • 21. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
    Sheehan DV; McElroy SL; Harnett-Sheehan K; Keck PE; Janavs J; Rogers J; Gonzalez R; Shivakumar G; Suppes T
    J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alpidem, a novel anxiolytic drug. A double-blind, placebo-controlled study in anxious outpatients.
    Bassi S; Albizzati MG; Ferrarese C; Frattola L; Cesana B; Piolti R; Farolfi A
    Clin Neuropharmacol; 1989 Feb; 12(1):67-74. PubMed ID: 2565767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the adverse reactions and efficacy of long-term treatment with flupirtine: preliminary results of an ongoing twelve-month study with 200 patients suffering from chronic pain states in arthrosis or arthritis.
    Herrmann WM; Kern U; Aigner M
    Postgrad Med J; 1987; 63 Suppl 3():87-103. PubMed ID: 2451818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quetiapine as an adjunctive pharmacotherapy for the treatment of non-remitting generalized anxiety disorder: a flexible-dose, open-label pilot trial.
    Katzman MA; Vermani M; Jacobs L; Marcus M; Kong B; Lessard S; Galarraga W; Struzik L; Gendron A
    J Anxiety Disord; 2008 Dec; 22(8):1480-6. PubMed ID: 18455360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Open study of clotiazepam (Clozan) in ambulatory anxious patients centered on a multifactorial evaluation using the AMDP and on a study of the rebound effect].
    Troisfontaines B; von Frenckell R; Bronckart C; Guiot-Goffioul F; Bobon D
    Acta Psychiatr Belg; 1987; 87(2):215-29. PubMed ID: 2887087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of generalized anxiety: new pharmacologic approaches].
    Boulenger JP
    Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
    Davidson JR; Meoni P; Haudiquet V; Cantillon M; Hackett D
    Depress Anxiety; 2002; 16(1):4-13. PubMed ID: 12203668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Naltrexone plus benzodiazepine aids abstinence in opioid-dependent patients.
    Stella L; D'Ambra C; Mazzeo F; Capuano A; Del Franco F; Avolio A; Ambrosino F
    Life Sci; 2005 Oct; 77(21):2717-22. PubMed ID: 15979652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abecarnil, a new beta-carboline, in the treatment of anxiety disorders.
    Aufdembrinke B
    Br J Psychiatry Suppl; 1998; (34):55-63. PubMed ID: 9829018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double-blind study of prazepam versus placebo in single daily doses in the treatment of anxiety.
    Goldberg HL; Finnerty RJ
    Compr Psychiatry; 1977; 18(2):147-55. PubMed ID: 319941
    [No Abstract]   [Full Text] [Related]  

  • 31. Double-blind, comparative study of cyamemazine vs. bromazepam in the benzodiazepine withdrawal syndrome.
    Lemoine P; Kermadi I; Garcia-Acosta S; Garay RP; Dib M
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):131-7. PubMed ID: 16243418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Steroid-sparing effect of wormwood (Artemisia absinthium) in Crohn's disease: a double-blind placebo-controlled study.
    Omer B; Krebs S; Omer H; Noor TO
    Phytomedicine; 2007 Feb; 14(2-3):87-95. PubMed ID: 17240130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of generalized anxiety disorder: preliminary clinical experience with buspirone.
    Petracca A; Nisita C; McNair D; Melis G; Guerani G; Cassano GB
    J Clin Psychiatry; 1990 Sep; 51 Suppl():31-9. PubMed ID: 2211564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trazodone in benzodiazepine dependence.
    Ansseau M; De Roeck J
    J Clin Psychiatry; 1993 May; 54(5):189-91. PubMed ID: 8509349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double-blind comparison of prazepam with diazepam, chlorazepate dipotassium and placebo in anxious out-patients.
    Fabre LF; McLendon DM; Mallette A
    J Int Med Res; 1979; 7(2):147-51. PubMed ID: 39012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prazepam in anxiety: a controlled clinical trial [proceedings].
    Rickels K; Downing RW
    Psychopharmacol Bull; 1977 Apr; 13(2):19-21. PubMed ID: 323905
    [No Abstract]   [Full Text] [Related]  

  • 37. Prazepam in anxiety: a controlled clinical trial.
    Rickels K; Sablosky L; Silverman H; Case WG; Rial W; Mirman M; Gottlieb S
    Compr Psychiatry; 1977; 18(3):239-49. PubMed ID: 858240
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of the effect of two prazepam formulations on psychomotor and cognitive function in healthy volunteers.
    Girre C; Bertaux L; Dussaucy E; Bonnet D; Palombo S; Fournier PE
    Int Clin Psychopharmacol; 1990 Jan; 5(1):57-64. PubMed ID: 2332608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of sublingual and oral prazepam in normal subjects. I. Clinical data.
    Ansseau M; von Frenckell R; Jacqmin P
    Neuropsychobiology; 1987; 18(2):77-82. PubMed ID: 3330182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progesterone co-administration in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal severity and taper outcome.
    Schweizer E; Case WG; Garcia-Espana F; Greenblatt DJ; Rickels K
    Psychopharmacology (Berl); 1995 Feb; 117(4):424-9. PubMed ID: 7604143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.